Regeneron Pharmaceuticals reported $2.89B in Cash and Equivalent for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Agios Pharmaceuticals AGIO:US $ 203.13M 197.1M
AstraZeneca AZN:LN 6329M 738M
Bluebird Bio BLUE:US $ 396.62M 5.84M
IONIS PHARMACEUT IONS:US $ 2115M 1482.05M
Novartis NOVN:VX SF 12407M 5196M
Ophthotech OPHT:US $ 191.87M 69.58M
Opthea Ltd OPT:AU 81.63M 21.02M
Teva Pharmaceutical TEVA:IT 2.16B 120M